Close Menu

Wall Street Journal reports that Carl Icahn won a seat on Biogen Idec's board of directors, with the results of a possible second seat still up in the air, according to the article. "Icahn, who owns about 5.6% of Biogen and favors its break-up or sale, has claimed his candidates won two seats on Biogen's 13-member board, after a months-long proxy fight that ended Wednesday with a raucous shareholder meeting in Cambridge, Mass.," the article says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.